Anti-Ageing Potential of Silphion Oral Collagen Powder

A Clinical Study to Evaluate the Anti-Ageing Activity of Silphion Oral Collagen Powder on Healthy Human Volunteers - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2025/02/081060

Enrollment

Registered

2025-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Oral Collagen Powder 5 gms per day: Test Product: Oral Collagen Powder, Take 5 grams of collagen powder daily. Add the powder to 100-150 ml of water, stir well, and drink.

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gender: Non-pregnant, non-lactating female aged between 30 to 55 (Female:Male ratio to be 80:20) 2) Subjects willing to give written informed consent 3) Women of child bearing potential must have a negative urine pregnancy test prior to study entry. 4) Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events. 5) Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1.Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study. 2.Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition. 3.Volunteers Allergic to Fish. 4.Volunteers Taking long term medication. 5.Have participated in any interventional clinical trial in the previous 30 days. 6.Have a known sensitivity to any of the constituents of the test product including sensitivities to (mention some of active ingredient s name) 7.Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids. 8.Have a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

Measure	Time frame
1. Change in Melanin index by mexameter 2. Change in Hydration by cornemeter 3. Change in Elasticity 4. Change in water loss through skin by TEWL 5. Change in Wrinkles and blemishes by Visio Scan 6.Change in under eye dark circleTimepoint: At t0 and t28	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org8937015757

Outcome results